Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

NCT00462488 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder Cancer
Bladder Cancer
Bladder Neoplasms
Bladder Tumors

Interventions

DRUG: Vicinium

Sponsor

Sesen Bio, Inc.